43Sc/47Sc-PSMA-617

N/A

Report date: 2025/11/14 09:32:43

NME

Base Information

Drug Name43Sc/47Sc-PSMA-617

Drug Alias NameScandium-43 (43Sc)/Scandium-47(47Sc)-PSMA-61743Sc/47Sc-PSMA-617

ClassificationSmall molecules > Synthetic peptideRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Scandium > 47Sc +[5]

Mechanisms of ActionProstate-Specific Membrane Antigen inhibitorsPositron-emission tomography enhancersIonising radiation emitters

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Chicago

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Chicago

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A